AroCell AroCell AB is an in vitro diagnostics company focusing on the monitoring of hematological malignancies, breast cancer, and other solid tumors. | Simphotek Simphotek is a biotechnology company developing medical devices for light-based cancer treatments. | Breathomix Breathomix is a company that provides solutions to diagnose and manage respiratory diseases, including asthma, COPD (chronic obstructive pulmonary disease), and lung cancer. | |||
Founding Date | Founding Date 2003 | Founding Date 2007 | Founding Date 2005 | Founding Date 2018 | Founding Date 2014 |
Type | Type Public | Type Private | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Uppsala, SE HQ | Locations Newark, US HQ | Locations Isfiya, IL HQ New York, US | Locations Leiden, NL HQ | Locations West Hollywood, US HQ |
Employees | Employees 2215% decrease | Employees 5 | Employees 85 | Employees 2 | Employees 7 |
Valuation ($) | Valuation ($) 14.3 m | Valuation ($) N/A | Valuation ($) 10.9 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) kr43m (FY, 2023) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods (kr397k) (FY, 2023) | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit kr43.9m (FY, 2023) | Gross profit N/A | Gross profit N/A | Gross profit N/A | Gross profit N/A |
Net income | Net income (kr59.3m) (FY, 2023) | Net income N/A | Net income ($17.6m) (FY, 2023) | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 56.1k | Total funding raised N/A | Total funding raised $ 39.3m | Total funding raised N/A | Total funding raised N/A |